Jeff Jennings - Equilibar

Jeff Jennings

Founder, Mechanical Engineer, Innovation Advisor

Jeff Jennings DuPont Forest

In 2007, Jeff Jennings founded Equilibar by moving his start-up technology business out of his basement into a testing and manufacturing facility near Asheville, NC. Today, Jeff holds more than a dozen fluid control patents, both in the U.S. and internationally, and continues to conduct active research in the Equilibar laboratory. He especially enjoys working to create technological breakthroughs in alternative energy, carbon sequestration, clean water and other emerging environmental fields.

“One of the most rewarding parts of my job has been working with creative scientists and engineers all over the world,” Jeff says. “I’ve enjoyed traveling to other countries and becoming familiar with other cultures and learning from them. It is gratifying to see how our technology can play a role in so many different types of cutting-edge applications across the U.S. and across the globe .”

A graduate of Clemson University, Jeff previously worked for the DuPont company and moved to Western North Carolina in 1991 as a research engineer at DuPont’s Brevard film manufacturing site. As founder of Equilibar, he worked to maintain a progressive workplace and to support STEM education in local public schools. He has been a mentor for the local robotics team and has participated in a variety of hands-on STEM education events. Now an advisor and mentor for both Equilibar and parent company Richards Industrials, Jeff advocates for an innovation mindset and spearheads explorations for new product development.

Jeff is known in the community for his active role in local conservation and environmental efforts, including the establishment of DuPont State Recreational Forest. He spends time outdoors whenever possible biking, hiking, and backpacking. His outdoor photography is on display at Equilibar.

Jeff is a licensed Professional Engineer in the state of North Carolina and serves on the advisory board for Process Instrumentation Magazine.

See Jeff’s LinkedIn profile.

Equilibar News
PUK magazine cover with stainless steel device

Journal article focuses on oligonucleotide production using pressure control with built in dampener

Oligonucleotide drugs are made up of short sections of genetic sequences and are used to target disorders in the genetic code. The first drug of this type was used in 1998 during the AIDS epidemic.  Since then, the field has accelerated rapidly and today many oligonucleotide drugs are in clinical trials, promising improvements in treatment Read More

Read More